Cargando…
Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
INTRODUCTION: Adult muscle fibers are a source of growth factors, including insulin-like growth factor-1 (IGF-1). These factors influence neuronal survival, axonal growth, and maintenance of synaptic connections. METHODS: We investigated the components of the IGF system in skeletal muscle samples ob...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306791/ https://www.ncbi.nlm.nih.gov/pubmed/22246875 http://dx.doi.org/10.1002/mus.22288 |
_version_ | 1782227243885395968 |
---|---|
author | Lunetta, Christian Serafini, Massimo Prelle, Alessandro Magni, Paolo Dozio, Elena Ruscica, Massimiliano Sassone, Jenny Colciago, Clarissa Moggio, Maurizio Corbo, Massimo Silani, Vincenzo |
author_facet | Lunetta, Christian Serafini, Massimo Prelle, Alessandro Magni, Paolo Dozio, Elena Ruscica, Massimiliano Sassone, Jenny Colciago, Clarissa Moggio, Maurizio Corbo, Massimo Silani, Vincenzo |
author_sort | Lunetta, Christian |
collection | PubMed |
description | INTRODUCTION: Adult muscle fibers are a source of growth factors, including insulin-like growth factor-1 (IGF-1). These factors influence neuronal survival, axonal growth, and maintenance of synaptic connections. METHODS: We investigated the components of the IGF system in skeletal muscle samples obtained from 17 sporadic amyotrophic lateral sclerosis patients (sALS) and 29 control subjects (17 with normal muscle and 12 with denervated muscle unrelated to ALS). RESULTS: The muscle expression of IGF-1 and IGF-binding proteins 3, 4, and 5 (IGF-BP3, -4, and -5, respectively), assessed by immunohistochemistry, was differently decreased in sALS compared with both control groups; conversely, IGF-1 receptor β subunit (IGF-1Rβ) was significantly increased. Western blot analysis confirmed the severe reduction of IGF-1, IGF-BP3, and -BP5 with the increment of IGF-1Rβ in sALS. CONCLUSION: In this study we describe the abnormal expression of the IGF-1 system in skeletal muscle of sALS patients that could participate in motor neuron degeneration and should be taken into account when developing treatments with IGF-1. Muscle Nerve, 2012 |
format | Online Article Text |
id | pubmed-3306791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Wiley Subscription Services, Inc., A Wiley Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-33067912012-03-19 Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients Lunetta, Christian Serafini, Massimo Prelle, Alessandro Magni, Paolo Dozio, Elena Ruscica, Massimiliano Sassone, Jenny Colciago, Clarissa Moggio, Maurizio Corbo, Massimo Silani, Vincenzo Muscle Nerve Research Articles INTRODUCTION: Adult muscle fibers are a source of growth factors, including insulin-like growth factor-1 (IGF-1). These factors influence neuronal survival, axonal growth, and maintenance of synaptic connections. METHODS: We investigated the components of the IGF system in skeletal muscle samples obtained from 17 sporadic amyotrophic lateral sclerosis patients (sALS) and 29 control subjects (17 with normal muscle and 12 with denervated muscle unrelated to ALS). RESULTS: The muscle expression of IGF-1 and IGF-binding proteins 3, 4, and 5 (IGF-BP3, -4, and -5, respectively), assessed by immunohistochemistry, was differently decreased in sALS compared with both control groups; conversely, IGF-1 receptor β subunit (IGF-1Rβ) was significantly increased. Western blot analysis confirmed the severe reduction of IGF-1, IGF-BP3, and -BP5 with the increment of IGF-1Rβ in sALS. CONCLUSION: In this study we describe the abnormal expression of the IGF-1 system in skeletal muscle of sALS patients that could participate in motor neuron degeneration and should be taken into account when developing treatments with IGF-1. Muscle Nerve, 2012 Wiley Subscription Services, Inc., A Wiley Company 2012-02 /pmc/articles/PMC3306791/ /pubmed/22246875 http://dx.doi.org/10.1002/mus.22288 Text en Copyright © 2011 Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Research Articles Lunetta, Christian Serafini, Massimo Prelle, Alessandro Magni, Paolo Dozio, Elena Ruscica, Massimiliano Sassone, Jenny Colciago, Clarissa Moggio, Maurizio Corbo, Massimo Silani, Vincenzo Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients |
title | Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients |
title_full | Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients |
title_fullStr | Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients |
title_full_unstemmed | Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients |
title_short | Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients |
title_sort | impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306791/ https://www.ncbi.nlm.nih.gov/pubmed/22246875 http://dx.doi.org/10.1002/mus.22288 |
work_keys_str_mv | AT lunettachristian impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT serafinimassimo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT prellealessandro impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT magnipaolo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT dozioelena impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT ruscicamassimiliano impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT sassonejenny impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT colciagoclarissa impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT moggiomaurizio impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT corbomassimo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients AT silanivincenzo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients |